Laboratorio Farmaceutico SIT (“SIT”) announces the acquisition of the pharmaceutical product DERINOX from Therabel Lucien Pharma Sas, a reference medicine among topical decongestants.

The product is indicated for the short-term symptomatic local treatment of congestive and inflammatory conditions during acute rhinitis, in adults and adolescents over 15 years of age.

This acquisition will enable SIT to strengthen and expand its product portfolio, further consolidating its growth path and presence in the French market, establishing itself as a reliable partner in international acquisitions of mature branded pharmaceuticals.

SIT continues along its path of innovation and development, reinforcing its offering and international presence to meet the needs of patients and healthcare professionals with high-quality and reliable solutions.

The M&A and Life Sciences team of De Berti Jacchia assisted SIT on all legal aspects of the transaction. The team was coordinated by Partner Pietro Meda, with the collaboration of Partner Claudio Corba Colombo and the support of Senior Associates Benedetta Mazzotti and Francesca Zironi.

Intellectual property aspects were handled by Partner Andrea Terragni, assisted by Senior Associate Laura Bussoli.

Banking aspects were overseen by Partner Giuseppe Cristiano.

Download the press review.

The post DE BERTI JACCHIA WITH LABORATORIO FARMACEUTICO SIT IN THE ACQUISITION OF DERINOX appeared first on Studio Legale De Berti Jacchia Franchini Forlani.

De Berti Jacchia assisted SogeMi S.p.A., the company that manages the Agri-Food Market and Neighborhood Markets on behalf of the Municipality of Milan, in connection with the redevelopment of the municipal market on Via Rombon, in Milan’s Lambrate district.

The initiative is part of the broader “Neighborhood Markets” project launched by the Municipality of Milan and entrusted to Sogemi, which envisages the redevelopment of 15 market buildings and an investment plan of approximately €25 million.

The redevelopment of the Rombon market has led to the complete revival of the historic market, transforming it into a modern, accessible hub ready to once again become a point of reference for the Lambrate community.

The transaction represents a decisive step toward the modernization and enhancement of Milan’s neighborhood market system. The project aims to create a synergistic network of markets located across the city’s districts, revitalizing their original role as local retail hubs, integrated with the broader food hub managed by Sogemi, the leading agri-food center in Milan and Lombardy.

De Berti Jacchia advised Sogemi on all legal aspects throughout the entire transaction, with a team composed of partner Pietro Meda, handling civil law and real estate matters, and partner Antonella Terranova, handling administrative law matters, both assisted by associate Francesca Zironi in the real estate area, ensuring comprehensive and continuous support at every stage of the project.

Download here the press review.

The post DE BERTI JACCHIA WITH SOGEMI IN THE REOPENING OF THE MUNICIPAL MARKET ON VIA ROMBON appeared first on Studio Legale De Berti Jacchia Franchini Forlani.

Laboratorio Farmaceutico SIT (hereinafter “SIT”) announces the acquisition of MIZOLLEN, a leading H1 long-acting antihistamine.

The product is indicated for the symptomatic treatment of seasonal allergic rhinitis (hay fever), perennial allergic rhinitis, and urticaria.

This acquisition will allow SIT to strengthen and expand its product portfolio, significantly increasing its presence in the French market and consolidating its role as a reliable partner in international acquisitions of mature branded pharmaceuticals.

SIT continues its path of innovation and growth, enhancing its offering and presence in international markets to meet the needs of patients and healthcare professionals with reliable, high-quality solutions.

The team at De Berti Jacchia – which advised SIT on all legal aspects of the transaction, overseeing and coordinating the deal structure as a whole – was led by partner Pietro Meda, with the support of partner Claudio Corba Colombo, both members of the M&A department, and assisted by senior associates Benedetta Mazzotti and Francesca Zironi.

Intellectual property matters were handled by partner Andrea Terragni, supported by senior associate Laura Bussoli.

Banking aspects were overseen by partner Giuseppe Cristiano.

Download the full press review here.

The post DE BERTI JACCHIA WITH LABORATORIO FARMACEUTICO SIT IN THE ACQUISITION OF MIZOLLEN appeared first on Studio Legale De Berti Jacchia Franchini Forlani.

Laboratorio Farmaceutico SIT (hereinafter “SIT”) announces the acquisition of the pharmaceutical product “DINTOINA”.
DINTOINA is a reference product for the treatment of generalized epilepsy, excluding petit mal and partial seizures.

In addition to its neurological applications, DINTOINA is also used in the treatment of other conditions, confirming its proven effectiveness across multiple therapeutic areas.

This acquisition marks a significant step in SIT’s growth strategy in the Central Nervous System (CNS) field and expands the pharmaceutical company’s portfolio.

With a presence in over 70 countries, and a pipeline of more than 75 branded pharmaceutical products, in addition to Medical Devices and Food Supplements, SIT continues its path of innovation and development, strengthening its offering to meet the needs of patients and healthcare professionals with reliable, high-quality solutions.

The law firm De Berti Jacchia assisted SIT throughout all phases of the transaction, from structuring the agreement to its finalization, with a dedicated team led by Partner Pietro Meda, supported by Associate Francesca Zironi. Intellectual property matters were handled by Partner Andrea Terragni and Associate Laura Bussoli.

The post DE BERTI JACCHIA WITH LABORATORIO FARMACEUTICO SIT IN THE ACQUISITION OF DINTOINA appeared first on Studio Legale De Berti Jacchia Franchini Forlani.

The post DE BERTI JACCHIA E ROMOLOTTI MARRETTA NELLA CESSIONE DEL RAMO DI AZIENDA DEDICATO AL FOOD DA PARTE DI COPERNICO & FRIENDS, SOCIETÀ DEL GRUPPO IWG appeared first on Studio Legale De Berti Jacchia Franchini Forlani.

Milan, July 15th, 2024 – Pietro Meda, a Supreme Court lawyer expert in corporate law and M&A, with a particular focus on the pharmaceutical, real estate, automotive, and e-sports sectors, joins De Berti Jacchia as a partner in the Milan office.

The post PIETRO MEDA NEW PARTNER IN DE BERTI JACCHIA appeared first on Studio Legale De Berti Jacchia Franchini Forlani.